Mark Jeng

机构：Memorial Sloan Kettering Cancer Center, Cornell University · ORCID：0000-0003-0854-761X

发表论文 45 篇 · 总被引 430 次 · h-index 7

代表论文

• Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases (2025 · Annals of Oncology · 被引 11)
• Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC (2025 · Journal of Thoracic Oncology · 被引 5)
• Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases (2025 · Journal of Thoracic Oncology · 被引 5)
• Cancer type-specific variation in patterns of driver alterations across 50,000 tumors (2026 · Cancer Cell · 被引 4)
• Clinicogenomic analysis of EGFR -mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation (2026 · Science Translational Medicine · 被引 1)
• Clinicogenomic determinants of early progression on first-line osimertinib in EGFR -mutant NSCLC. (2026 · Journal of Clinical Oncology · 被引 1)